These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. CCR1 antagonist J-113863 corrects the imbalance of pro- and anti-inflammatory cytokines in a SJL/J mouse model of relapsing-remitting multiple sclerosis. Ansari MA, Nadeem A, Attia SM, Bakheet SA, Shahid M, Rehman MU, Alanazi MM, Alhamed AS, Ibrahim KE, Albekairi NA, Ahmad SF. Immunobiology; 2022 Sep; 227(5):152245. PubMed ID: 35868215 [Abstract] [Full Text] [Related]
24. Exosomes derived from mesenchymal stem cells attenuate inflammation and demyelination of the central nervous system in EAE rats by regulating the polarization of microglia. Li Z, Liu F, He X, Yang X, Shan F, Feng J. Int Immunopharmacol; 2019 Feb; 67():268-280. PubMed ID: 30572251 [Abstract] [Full Text] [Related]
27. Calcitonin gene-related peptide decreases IL-1beta, IL-6 as well as Ym1, Arg1, CD163 expression in a brain tissue context-dependent manner while ameliorating experimental autoimmune encephalomyelitis. Rossetti I, Zambusi L, Finardi A, Bodini A, Provini L, Furlan R, Morara S. J Neuroimmunol; 2018 Oct 15; 323():94-104. PubMed ID: 30196840 [Abstract] [Full Text] [Related]
28. Mitogen-activated protein kinase inhibitor PD98059 improves neuroimmune dysfunction in experimental autoimmune encephalomyelitis in SJL/J mice through the inhibition of nuclear factor-kappa B signaling in B cells. Alomar HA, Nadeem A, Ansari MA, Attia SM, Bakheet SA, Al-Mazroua HA, Alhazzani K, Assiri MA, Alqinyah M, Almudimeegh S, Ahmad SF. Brain Res Bull; 2023 Mar 15; 194():45-53. PubMed ID: 36646144 [Abstract] [Full Text] [Related]
30. Histamine H4 Receptor Agonist, 4-Methylhistamine, Aggravates Disease Progression and Promotes Pro-Inflammatory Signaling in B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model. Alsaad AMS, Ansari MA, Nadeem A, Attia SM, Bakheet SA, Alomar HA, Ahmad SF. Int J Mol Sci; 2023 Aug 20; 24(16):. PubMed ID: 37629172 [Abstract] [Full Text] [Related]
31. An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response. Choi JH, Lee MJ, Jang M, Kim EJ, Shim I, Kim HJ, Lee S, Lee SW, Kim YO, Cho IH. PLoS One; 2015 Aug 20; 10(10):e0138592. PubMed ID: 26444423 [Abstract] [Full Text] [Related]
33. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis. Whitham RH, Bourdette DN, Hashim GA, Herndon RM, Ilg RC, Vandenbark AA, Offner H. J Immunol; 1991 Jan 01; 146(1):101-7. PubMed ID: 1701788 [Abstract] [Full Text] [Related]
34. Paricalcitol improves experimental autoimmune encephalomyelitis (EAE) by suppressing inflammation via NF-κB signaling. Zhang D, Qiao L, Fu T. Biomed Pharmacother; 2020 May 01; 125():109528. PubMed ID: 32106388 [Abstract] [Full Text] [Related]
35. Pien Tze Huang Alleviates Relapsing-Remitting Experimental Autoimmune Encephalomyelitis Mice by Regulating Th1 and Th17 Cells. Qiu X, Guo Q, Liu X, Luo H, Fan D, Deng Y, Cui H, Lu C, Zhang G, He X, Lu A. Front Pharmacol; 2018 May 01; 9():1237. PubMed ID: 30429789 [Abstract] [Full Text] [Related]
37. COX-2 inhibitors modulate IL-12 signaling through JAK-STAT pathway leading to Th1 response in experimental allergic encephalomyelitis. Muthian G, Raikwar HP, Johnson C, Rajasingh J, Kalgutkar A, Marnett LJ, Bright JJ. J Clin Immunol; 2006 Jan 01; 26(1):73-85. PubMed ID: 16418805 [Abstract] [Full Text] [Related]
38. Oral administration of triptolide ameliorates the clinical signs of experimental autoimmune encephalomyelitis (EAE) by induction of HSP70 and stabilization of NF-kappaB/IkappaBalpha transcriptional complex. Kizelsztein P, Komarnytsky S, Raskin I. J Neuroimmunol; 2009 Dec 10; 217(1-2):28-37. PubMed ID: 19796825 [Abstract] [Full Text] [Related]